These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14696025)

  • 1. Prolonged QTc intervals in medicated patients with schizophrenia.
    Chong SA; Mythily ; Lum A; Goh HY; Chan YH
    Hum Psychopharmacol; 2003 Dec; 18(8):647-9. PubMed ID: 14696025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia.
    Ozeki Y; Fujii K; Kurimoto N; Yamada N; Okawa M; Aoki T; Takahashi J; Ishida N; Horie M; Kunugi H
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):401-5. PubMed ID: 20079791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduction of prolonged QTc-interval related risks in treatment with neuropharmacological drugs. Recommendations for clinical practice].
    van de Kraats GB; Slob J; Tenback DE
    Tijdschr Psychiatr; 2007; 49(1):43-7. PubMed ID: 17225205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic drugs associated with corrected QT interval prolongation.
    van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of QT interval in patients treated with psychotropic drugs.
    Novotny T; Florianova A; Ceskova E; Weislamplova M; Palensky V; Tomanova J; Sisakova M; Toman O; Spinar J
    Int J Cardiol; 2007 May; 117(3):329-32. PubMed ID: 16863665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QTc-interval abnormalities in a forensic population.
    Girgis S; Huckstep B; Oakley J; Ferriter M; Nikolaou V
    Crim Behav Ment Health; 2007; 17(2):75-88. PubMed ID: 17295199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugs.
    Vieweg WV
    J Clin Psychiatry; 2002; 63 Suppl 9():18-24. PubMed ID: 12088172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in QT dispersion in medicated schizophrenia patients following electroconvulsive therapy.
    Nahshoni E; Manor N; Bar F; Stryjer R; Zalsman G; Weizman A
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):121-5. PubMed ID: 15013027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
    Glassman AH
    J Clin Psychiatry; 2005; 66 Suppl 6():5-10. PubMed ID: 16107178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QTc interval in a sample of long-term schizophrenia inpatients.
    Ramos-Ríos R; Arrojo-Romero M; Paz-Silva E; Carballal-Calvo F; Bouzón-Barreiro JL; Seoane-Prado J; Codesido-Barcala R; Crespí-Armenteros A; Fernández-Pérez R; López-Moríñigo JD; Tortajada-Bonaselt I; Diaz FJ; de Leon J
    Schizophr Res; 2010 Jan; 116(1):35-43. PubMed ID: 19892525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia.
    Tay JK; Tan CH; Chong SA; Tan EC
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1297-302. PubMed ID: 17611010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
    Minov C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S142-4. PubMed ID: 15570533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QTc dispersion in haemodialysis patients with cardiac complications.
    Nakamura S; Ogata C; Aihara N; Sasaki O; Yoshihara F; Nakahama H; Inenaga T; Kimura G; Kawano Y
    Nephrology (Carlton); 2005 Apr; 10(2):113-8. PubMed ID: 15877668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged QTc intervals on admission electrocardiograms: prevalence and correspondence with admission electrolyte abnormalities.
    Golzari H; Dawson NV; Speroff T; Thomas C
    Conn Med; 2007 Aug; 71(7):389-97. PubMed ID: 17879860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QTc prolongation in schizophrenia patients in Asia: clinical correlates and trends between 2004 and 2008/2009.
    Xiang YT; Chiu HF; Ungvari GS; Correll CU; Lai KY; Wang CY; Si TM; Lee EH; He YL; Yang SY; Chong MY; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Tan CH; Shinfuku N
    Hum Psychopharmacol; 2015 Mar; 30(2):94-9. PubMed ID: 25611192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
    Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.